These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 330440)

  • 61. Antidepressive treatment and mood swing patterns in endogenous depression.
    Strian F; Albert W; Klicpera C
    Pharmakopsychiatr Neuropsychopharmakol; 1979 Nov; 12(6):432-7. PubMed ID: 538088
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Double-bind comparison of maprotiline with amitriptyline in the treatment of depressive illness.
    Trick KL
    Int Pharmacopsychiatry; 1975; 10(4):193-8. PubMed ID: 765292
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Antidepressant drugs in anergic schizophrenia. A double-blind cross-over study with maprotiline and placebo.
    Waehrens J; Gerlach J
    Acta Psychiatr Scand; 1980 May; 61(5):438-44. PubMed ID: 6105762
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Controlled trial on the possible advantages of a combined therapy with maprotiline and haloperidol in endogenous depression.
    Möller HJ; Kissling W; Herberger B; Binz U; Wendt G; Spahn H
    Pharmacopsychiatry; 1986 Sep; 19(5):362-4. PubMed ID: 3534899
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical and biological parameters as predictors for antidepressant drug responses in depressed patients.
    Fähndrich E
    Pharmacopsychiatria; 1983 Nov; 16(6):179-85. PubMed ID: 6665027
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Nomifensine and maprotiline in endogenous depression: comparative efficacy and side effects.
    Levin A
    Int Pharmacopsychiatry; 1982; 17 Suppl 1():89-96. PubMed ID: 6752081
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A double-blind comparison of mianserin and maprotiline in depressed medically ill elderly people.
    Schifano F; Garbin A; Renesto V; De Dominicis MG; Trinciarelli G; Silvestri A; Magni G
    Acta Psychiatr Scand; 1990 Mar; 81(3):289-94. PubMed ID: 2188479
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Maprotiline in affective illness. Plasma concentration and clinical response.
    Norman TR; Burrows GD; Maguire KP; McIntyre IM; Scoggins BA
    J Affect Disord; 1983 May; 5(2):147-54. PubMed ID: 6222094
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Maprotiline and doxepin in the treatment of depression. A double-glind multicentre comparison.
    Väisänen E; Naarala M; Kontiainen H; Meriläinen V; Heikkilä L; Malinen L
    Acta Psychiatr Scand; 1978 Mar; 57(3):193-201. PubMed ID: 347885
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Intravenous maprotiline in severe and resistant primary depression: a double-blind comparison with clomipramine.
    Drago F; Motta A; Grossi E
    J Int Med Res; 1983; 11(2):78-84. PubMed ID: 6343154
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Antidepressant treatment with maprotiline in the management of emotional disturbances in patients with acute myocardial infarction: a controlled study.
    Selvini A; Rossi C; Belli C; Corallo S; Lucchelli PE
    J Int Med Res; 1976; 4(1):42-9. PubMed ID: 799978
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparison of the efficacy of sustained-release amitriptyline with maprotiline in the treatment of depressive illness.
    Sims AC
    Curr Med Res Opin; 1980; 6(8):534-9. PubMed ID: 7389384
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A clinical trial with nomifensin, a new antidepressant drug.
    Pecknold JC; Ban TA; Lehmann HE; Klingner A
    Int J Clin Pharmacol Biopharm; 1975 Jun; 11(4):304-8. PubMed ID: 125727
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [A new "tetracyclic" antidepressive drug: maprotiline].
    Schouteden P; Bataille M
    Rev Med Liege; 1977 May; 32(10):317-27. PubMed ID: 887880
    [No Abstract]   [Full Text] [Related]  

  • 75. Chemistry, pharmacology, pharmacokinetics, adverse effects, and efficacy of the antidepressant maprotiline hydrochloride.
    Wells BG; Gelenberg AJ
    Pharmacotherapy; 1981; 1(2):121-39. PubMed ID: 6765485
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [The pharmacotherapy of masked depression].
    Kielholz VP
    Wien Med Wochenschr; 1975 May; 125(21):327-9. PubMed ID: 3030
    [No Abstract]   [Full Text] [Related]  

  • 77. Does lofepramine have fewer side effects than amitriptyline? Results of a comparative trial.
    Pugh R; Bell J; Cooper AJ; Dunstan S; Greedharry D; Pomeroy J; Raptopoulos P; Rowsell C; Steinert J; Priest RG
    J Affect Disord; 1982 Dec; 4(4):355-63. PubMed ID: 6219149
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Therapy of elderly depressive patients. Lofepramine and amitriptyline under double-blind conditions].
    Jessel HJ; Jessel I; Wegener G
    ZFA (Stuttgart); 1981 Apr; 57(10):784-8. PubMed ID: 7015714
    [No Abstract]   [Full Text] [Related]  

  • 79. Maprotiline and amitriptyline in the treatment of depressive illness. A double-blind comparison.
    Levin A
    S Afr Med J; 1974 Jan; 48(2):47-9. PubMed ID: 4595136
    [No Abstract]   [Full Text] [Related]  

  • 80. Symptom reduction in depressed outpatients treated with amitriptyline or maprotiline: repeated measurement analysis.
    Prusoff BA; Weissman MM; Tanner J; Lieb J
    Compr Psychiatry; 1976; 17(6):749-54. PubMed ID: 791572
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.